avax technologies inc (AVXT:OTC US)
avax technologies inc (AVXT) Snapshot
|
Open
$0.0071
|
Previous Close
$0.0081
|
|
|
Day High
$0.0071
|
Day Low
$0.0071
|
|
|
52 Week High
05/21/12 - $0.07
|
52 Week Low
02/19/13 - $0.0009
|
|
|
Market Cap
1.0M
|
Average Volume 10 Days
53.5K
|
|
|
EPS TTM
$-0.04
|
Shares Outstanding
142.6M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
avax technologies inc (AVXT) Related Businessweek News
No Related Businessweek News Foundavax technologies inc (AVXT) Details
AVAX Technologies, Inc., a development stage biopharmaceutical company, specializes in the development and commercialization of vaccine therapies and other technologies for the treatment of cancer. The company’s autologous cell vaccine immunotherapy products include M-VAX intended for the treatment of melanoma is under phase II clinical trials; and O-VAX intended for the treatment for ovarian cancer is under phase I/II trials. It also provides contract manufacturing and research services. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.
| Recently Viewed | |||
| AVXT:US | $0.01 USD | -0.001 |  |
| Company | Last | Change | |
| No competitor information is available for AVXT. | |||
| View Industry Companies | |||
Industry Analysis
AVXT
Industry Average
| Valuation | AVXT | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 31.0x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact AVAX TECHNOLOGIES INC, please visit www.avax-tech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
